Reduced healthy life expectancy due to the high burden of both mental ill health and noncommunicable diseases (NCDs) is a major public health concern in the European Region. The links between mental disorders and major NCDs are well established.
In clinical practice, however, mental disorders in pa...tients with NCDs as well as NCDs in patients with mental disorders are often overlooked. Premature mortality and disability could be reduced if there were a greater focus on comorbidity.
This report addresses the needs of adults of working age with mental health problems – those with common mental disorders such as depression and anxiety and those with more severe conditions such as schizophrenia and bi-polar affective disorder. It also addresses the needs of those with NCDs, specifically cardiovascular diseases, cancers, chronic respiratory diseases and diabetes mellitus.
more
Mental disorders are one of the top public health challenges in the WHO European Region, affecting about 25% of the population every year. In all countries, mental health problems are much more prevalent among the people who are most deprived. The WHO European Region therefore faces diverse challeng...es affecting both the mental well-being of the population and the provision and quality of care for people with mental health problems.
The European Mental Health Action Plan focuses on seven interlinked objectives and proposes effective action to strengthen mental health and well-being. Investing in mental health is essential for the sustainability of health and socioeconomic policies in the European Region. The Action Plan corresponds to the four priority areas of the European policy framework for health and wellbeing, Health 2020, and will contribute directly to its implementation.
more
Rapport mondial sur les drogues 2018
Published: February 23, 2010
https://doi.org/10.1371/journal.pmed.1000235
Volume 7 | Issue 2 | e1000235
Introducción
Capítulo A.7
Edición en español
Editor: Juan José García-Orozco
Traducción: Juan José García-Orozco y Carlos González Vivas
Revisor de traducción: Laura Borredá Belda
Trastornos externalizantes
Capítulo D.3
Edición: Matías Irarrázaval & Andres Martin
Traducción: Fernanda Prieto Tagle, Sofía Hacohen Domené
Trastornos del ánimo
Capítulo E.2
Editores: Matías Irarrázaval & Andres Martin Traductores:
Traducción: Fernanda Prieto-Tagle & Ester Mora
Trastornos de ansiedad
Capítulo F.1
Edición en español
Editor: Matías Irarrázaval
Traducción: Matías Irarrázaval y María Tatiana Estefan
Trastornos de ansiedad
Capítulo F.2
Versión en español:
Editor: Cesar Soutullo
Traductores: Andrea Candelas-Muñoz, Cecilia Hernández-González, Ana Mena
Epilepsia, 55(4):475–482, 2014
doi: 10.1111/epi.12550
Q10: Are antidepressants (Tricyclic antidepressants (TCA), Selective serotonin reuptake inhibitors (SSRIs)) effective and safe in children 6-12 years of age with depressive episode/disorder?
Trouble de l'humeur
Chapitre E.2
Edition en français Traduction : Xavier Benarous Sous la direction de : David Cohen Avec le soutien de la SFPEADA
Autres troubles
Chapitre H.5
Edition en français Traduction : Bojan Mirkovic Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
Psychiatrie de l'enfant
Chapitre B.1
Edition en français
Traduction : Apolline Morville
Sous la direction de : Priscille Gérardin
Avec le soutien de la SFPEADA
Introducción
Capítulo A.1
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14.
Pediatría
Capítulo I.2
Editores: Laura Borredá Belda, Matías Irarrázaval & Andres Martin
Traducción: Alfonso Pastor Romero, Silvia Rodriguez Portillo, Carla Andreia Carvalho Gómez, María Tatiana Stefan & Paula Cox